Larimar Therapeutics, Inc. (LRMR)
Nasdaq: LRMR · Pharmaceutical Preparations · Bala Cynwyd, PA · filing with the SEC since 2006
Filings
338 filings since 2017 beside 177 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Apr 20, 2026.
Filings a yearinsider forms included
5283424444534750
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Sep 29, 2026.SEC letters: 2 in the last 36 months, the newest May 22, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jan 22, 2026
8-K items 3.02, 5.03, 9.01
Shares sold without registration; Charter, bylaw or fiscal-year change · Current report
Jan 21, 2026
Dec 17, 2025
8-K items 3.02, 5.03, 9.01
Shares sold without registration; Charter, bylaw or fiscal-year change · Current report
Dec 16, 2025
40 of 338 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.